(NYSE: CHE) Chemed's forecast annual revenue growth rate of 4.22% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.18%.
Chemed's revenue in 2025 is $2,511,915,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2025 to be $37,522,114,625, with the lowest CHE revenue forecast at $36,385,522,415, and the highest CHE revenue forecast at $39,022,999,210. On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $40,043,017,860, with the lowest CHE revenue forecast at $38,119,554,120, and the highest CHE revenue forecast at $42,141,341,940.
In 2027, CHE is forecast to generate $41,500,187,360 in revenue, with the lowest revenue forecast at $40,261,593,285 and the highest revenue forecast at $43,132,217,200.